Srikem Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MECLIZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 22933.
Remarkably, this DMF maintains an Active status since its submission on July 08, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 07, 2015, and payment made on December 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II